Previous 10 | Next 10 |
home / stock / alpmf / alpmf news
2023-05-01 09:12:47 ET Apellis Pharmaceuticals ( NASDAQ: APLS ) stock weakness, down 7.1% in premarket trading, is a buying opportunity after competitor Iveric Bio ( ISEE ) agreed to be sold to Astellas Pharma ( OTCPK:ALPMF ) for $5.9 billion on Sunday, according to ...
2023-05-01 08:52:41 ET Apellis Pharmaceuticals ( NASDAQ: APLS ) stock weakness, down 7.1% in premarket trading, is a buying opportunity after competitor Iveric Bio ( ISEE ) agreed to be sold to Astellas Pharma ( OTCPK:ALPMF ) for $5.9 billion on Sunday, according to ...
2023-05-01 07:16:39 ET Listen on the go! Subscribe to Wall Street Breakfast on Apple Podcasts and Spotify First Republic Bank ( FRC ) is seized, will be sold to JPMorgan. Nornickel ( NILSY ) board recommends no dividend for first time since 20...
2023-04-29 11:32:07 ET Astellas Pharma Inc. (ALPMF) Q4 2022 Results Conference Call April 27, 2023 03:00 AM ET Company Participants Hiromitsu Ikeda - Corporate Head, Advocacy and Relations Naoki Okamura - Representative Director, President and CEO Yoshitsugu Shit...
2023-04-24 08:39:37 ET For further details see: Lantheus, POINT Biopharma receive FDA Fast Track status for prostate cancer candidate
2023-04-19 06:39:26 ET Summary Biotechnology is the second worst performer in healthcare, significantly lagging behind the US market year-to-date. However, there could now be opportunities to get a bargain in the biotechs. Kura Oncology may be of interest to investors as this US b...
2023-04-04 08:35:08 ET Summary Its lead drug candidate is in Phase 3 development for multiple leukemia indications. Mechanism has utility in other cancer and non-cancer diseases. Perceived trial delays punished the stock. Delays actually raise the odds of greater survival ...
2023-04-01 16:00:21 ET Pfizer's ( NYSE: PFE ) acquisition of Seagen ( NASDAQ: SGEN ), announced in March, is expected to complement the pharma giant's current portfolio of oncology therapies. Seagen focuses on antibody-drug conjugates (ADCs), a technology that the co...
2023-03-29 04:41:23 ET Astellas Pharma ( OTCPK:ALPMF ) ( OTCPK:ALPMY ) is collaborating with Roche Diabetes Care Japan to develop and commercialize Roche's Accu-Chek Guide Me blood glucose monitoring system as a combined product with an app called BlueStar. Astellas s...
2023-03-15 09:10:29 ET The Biden administration on Wednesday published a list of 27 Medicare Part B drugs that will be subject to inflation penalties for the first time in the U.S., including some key pipeline products from AbbVie ( ABBV ), Gilead ( GILD ), and Seagen ( SGEN ...
News, Short Squeeze, Breakout and More Instantly...
Astellas Pharma Inc Company Name:
ALPMF Stock Symbol:
OTCMKTS Market:
Pharmaceutical stocks were initially expected to be largely immune to the COVID-19 economic downturn. Drugmakers, after all, generally produce products that are essential to daily life. However, the extreme social distancing that has become part and parcel of this unusual period has halted nume...
One of England's top healthcare watchdogs, the National Institute for Health and Care Excellence (NICE), has officially decided to stay the course and reject AstraZeneca 's (NYSE: AZN) lung cancer drug Tagrisso. A few months ago, the pharmaceutical giant argued that the drug should receive...
This past year proved profitable for investors in Incyte (NASDAQ: INCY) and Seattle Genetics (NASDAQ: SGEN) . Handily beating broad market and biotech indexes, these two drug manufacturers hit the $20 billion valuation mark and are poised to continue growing in the coming year -- unless, ...